Recursion Pharma operates at the intersection of biology and machine learning, building automated wet-lab infrastructure that generates massive biological datasets and training AI models to identify drug candidates from cellular imaging data. The company's engineering challenges include processing petabytes of high-content microscopy images, developing foundation models for biological data, and building pipelines that connect computational predictions to wet-lab validation at unprecedented scale. Their platform spans computer vision, large-scale data engineering, and ML infrastructure optimized for scientific discovery rather than traditional software workloads. Recursion's hiring patterns reveal growing demand for engineers who can bridge biological domain expertise with production ML systems, reflecting the broader convergence of AI and drug discovery.
| Location | Listings |
|---|